Trial Profile
A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Growth disorders; Short stature; Somatotropin deficiency
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 16 May 2015 New trial record